Increasing teenage population and unhealthy food habits is expected to boost the growth of the global acne treatment market at a CAGR of 4.63% during the 2022 to 2030

Market Research Future (MRFR) has published a cooked research report onthe "Global Acne Treatment Market" containing the information from 2022 to 2030.

Market Overview

During the forecast period (2022-2030), the acne treatments market is expected to expand from USD 9.6 billion in 2022 to USD 13.2 billion in 2030, representing a CAGR of 4.63%. 

Market Dynamics

The rising incidence of acne vulgaris among both adolescents and adults, the popularity of unhealthy fast food, and the desire for non-invasive cosmetic treatment options have all contributed to the market's rapid growth. Acne treatments have grown in popularity in part because they emphasize the importance of a healthy diet. Furthermore, a lot of money has been poured into the acne treatment industry because of the rising demand for better therapies. Minimally invasive cosmetic treatments are growing in popularity around the world. Treatment of skin diseases is mostly limited to topical medicines or minimally invasive treatments by dermatologists. During the assessment time frame, this factor has also served as a driver for the international market.

However, industry growth is being stymied by worries about the security of acne drugs. The fast spread of COVID-19 is currently impacting many different sectors and markets. Medical facilities have been forced to reorganize their operations in response to the COVID-19 pandemic. Rapid advancement in researching and manufacturing a wide range of medical supplies that are crucial in times of disaster has taken on increased importance in light of the shifting needs.

Segmental Analysis

The acne treatment market has been divided based on acne type, treatment, drug type, route of administration, and end user.

Based on acne type, has been segmented into moderate acne, mild acne, moderate to severe acne.

The acne treatment market is categorised by type of treatment into pharmaceutical and therapeutic devices.

The acne treatment market is categorised into laser treatment and microdermabrasion.

The acne treatment market has been split by drug type into OTC and prescription.

Based on end user, the acne treatment market is split into hospitals & clinics and specialised centres.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Acne Treatment Market Research Report

Regional Overview

According to region, the worldwide acne treatment market has been segmented into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas are expected to maintain their position as the largest market for acne treatments throughout the forecast period, which began in 2019. This is due to a number of factors, including the prevalence of acne and other skin issues in the region, the availability of new treatments, and technological advances. The United States plays a pivotal role in the expansion of the acne treatment market in the Americas.

Due to companies' intentions for organic expansion and the region's thriving medical industry, Europe was the second-largest market for acne treatment in 2019. The leading companies in the acne treatment market in the region are putting a lot of resources into coming up with new products and getting them to market.

Between 2020 and 2027, Asia-Pacific will presumably advance at the quickest rate. The widespread incidence of acne, increased government interest, and the presence of multiple pharmaceutical firms are all contributing factors. The expansion of the local market is fueled in part by the government's efforts to improve healthcare delivery. The increasing demand for acne treatments in Asia can be attributed to the region's aging population and the rising disposable income of middle-class households, which together make up the vast majority of the continent's population.

In recent years, the market for acne treatments in the MENA region has grown rapidly. Market growth is being fueled by factors such as the rising incidence of acne and investment from private companies and government organizations.

Competitive Analysis

The notable players of the market are GlaxoSmithKline plc (UK), Almirall, S.A. (Spain), Galderma Laboratories LP (US), F. Hoffman La Roche Ltd. (Switzerland), Bausch Health Companies Inc. (Canada), Leo Pharma A/S (Denmark), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Candela Corporation (US), and Vyne Therapeutics Inc. (US).